WA
GILD icon

Westfuller Advisors’s Gilead Sciences GILD Stock Holding History

Westfuller Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Sell
926
-37
-4% -$4.88K 0.04% 210
2026
Q1 		$134K Sell
963
-477
-33% -$66.8K 0.06% 173
2025
Q4 		$177K Sell
1,440
-63
-4% -$7.66K 0.07% 157
2025
Q3 		$167K Buy
+1,503
New +$171K 0.08% 164

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Westfuller Advisors's GILD Position: Q2 2026 in Review

Westfuller Advisors reduced its Gilead Sciences (GILD) stake by 3.8% in Q2 2026, selling an estimated $4.88K and leaving 926 shares worth $117K. The position accounts for 0.04% of the portfolio, ranked #210.

Westfuller Advisors first reported a position in GILD in Q3 2025 and has held it in 4 quarters since. The position peaked at $177K in Q4 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Westfuller Advisors held 926 shares of Gilead Sciences worth $117K as of Q2 2026.
  • Westfuller Advisors sold 37 Gilead Sciences shares in Q2 2026, an estimated $4.88K.
  • Gilead Sciences made up 0.04% of Westfuller Advisors's portfolio in Q2 2026, its #210 holding.
  • Westfuller Advisors first reported a position in Gilead Sciences in Q3 2025 and has held it in 4 quarters since.
  • Westfuller Advisors's Gilead Sciences position peaked at $177K in Q4 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Westfuller Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.